These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3480633)

  • 41. [Hemosorption in the combined therapy of suppurative-septic processes of the maxillofacial area].
    Zakharov IuS; Bolgov DF
    Stomatologiia (Mosk); 1985; 64(3):45-7. PubMed ID: 3863281
    [No Abstract]   [Full Text] [Related]  

  • 42. [Indications for the use of tactivin in the combined treatment of phlegmons of the maxillofacial area].
    Drobyshev VIu; Volozhin AI; Agapov VS; Sashkina TI
    Stomatologiia (Mosk); 1996; 75(4):27-30. PubMed ID: 8992659
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Complex therapy of purulent inflammatory diseases of the soft tissues of the face and jaw, using prodigiosan].
    Tsepov LM
    Stomatologiia (Mosk); 1975; 54(2):28-31. PubMed ID: 1055482
    [No Abstract]   [Full Text] [Related]  

  • 44. [Species and quantitative microfloral indices in phlegmons of the maxillofacial area].
    Mironov AIu; Pashkov EP; Chernoglazova EM
    Stomatologiia (Mosk); 1988; 67(5):42-3. PubMed ID: 3212806
    [No Abstract]   [Full Text] [Related]  

  • 45. [Treatment experience with suppurative-inflammatory processes of the maxillofacial region].
    Mukhsinov ME; Ashanin IA
    Stomatologiia (Mosk); 1977; 56(4):88-9. PubMed ID: 268060
    [No Abstract]   [Full Text] [Related]  

  • 46. [Iruxol treatment trials in suppurative wounds].
    Matiashin IM; Mendel' AK; Iaremchuk AIa; Karaban NI
    Sov Med; 1981; (3):65-8. PubMed ID: 6264634
    [No Abstract]   [Full Text] [Related]  

  • 47. [Action of UV irradiation on wound healing after incising maxillofacial phlegmons].
    Nanuev SI; Zausaev VI; Kats AG; Malomud ZP
    Stomatologiia (Mosk); 1984; 63(5):43-5. PubMed ID: 6593917
    [No Abstract]   [Full Text] [Related]  

  • 48. [Enzyme therapy of patients with pyo-inflammatory disease of maxillofacial area].
    Minaev SV; Ibragimov OR; Zelenskiĭ VA; Minaeva NV
    Voen Med Zh; 2007 Nov; 328(11):25-7, 96. PubMed ID: 18306709
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of helium-neon laser radiation in the combined treatment of phlegmon of the maxillofacial area].
    Chavchanidze TO; Shapiro AM
    Stomatologiia (Mosk); 1986; 65(4):33-5. PubMed ID: 3462978
    [No Abstract]   [Full Text] [Related]  

  • 50. [Nonspecific resistance and inflammation in patients with odontogenic phlegmons of the maxillofacial area].
    Rogov KA; Brusina LI; Ter-Asaturov GP
    Arkh Patol; 1988; 50(7):38-45. PubMed ID: 3190480
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The prediction of the outcomes of severe odontogenic inflammatory diseases of the maxillofacial area taking into account biorhythms].
    Taĭchenachev AIa
    Stomatologiia (Mosk); 1998; 77(6):15-8. PubMed ID: 10067408
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Changes in the factors of nonspecific protection of the body during treatment of inflammatory diseases of the maxillofacial area in elderly persons using prodigiozan].
    Zakson ML; Bordonos VG
    Stomatologiia (Mosk); 1987; 66(6):9-11. PubMed ID: 3481503
    [No Abstract]   [Full Text] [Related]  

  • 53. [Nonspecific body resistance in the acetylator phenotype of patients with odontogenic inflammatory processes in the maxillofacial area].
    Azimov M; Krakovskiĭ ME; Ashirmetov AKh
    Stomatologiia (Mosk); 1990; 69(6):33-5. PubMed ID: 2087715
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MODERN TREATMENT METHODS OF PHLEGMON IN THE MAXILLO-FACIAL AREA AND NECK.
    Malanchuk V; Sidoryako A; Vardzhapetian S
    Georgian Med News; 2019 Sep; (294):57-61. PubMed ID: 31687950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of maxillofacial phlegmon using hyperbaric oxygenation].
    Bazhanov NN; Kasparova BV; Shalabaev KZ; Lyskin GI
    Stomatologiia (Mosk); 1982; 61(3):37-9. PubMed ID: 6956007
    [No Abstract]   [Full Text] [Related]  

  • 56. [Kallikrein-kinin system and the blood cortisol level of patients with maxillofacial phlegmons].
    Karandashov VI; Chirkova LD; Sergeeva NA
    Stomatologiia (Mosk); 1983; 62(5):46-8. PubMed ID: 6579757
    [No Abstract]   [Full Text] [Related]  

  • 57. [Use of lamellar sutures in the combined treatment of phlegmons and abscesses of the maxillofacial area].
    Nanuev SI; Zausaev VI
    Stomatologiia (Mosk); 1985; 64(4):37-8. PubMed ID: 3901407
    [No Abstract]   [Full Text] [Related]  

  • 58. [Use of heteroperitoneum in the treatment of maxillofacial phlegmons].
    Gurov PN; Balmukhanov VN
    Vestn Khir Im I I Grek; 1970 Aug; 105(8):13-6. PubMed ID: 5495080
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effectiveness of using baliz-2 for treating suppurative wounds of the soft tissues].
    Timofeev AA
    Sov Med; 1988; (12):116. PubMed ID: 3242110
    [No Abstract]   [Full Text] [Related]  

  • 60. [Neutrophil-macrophage correlations during the healing of suppurative wounds in patients with phlegmons of the maxillofacial area undergoing combined treatment with the use of low-frequency ultrasound].
    Mukhsinov ME; Bazhanov NN; Pol'skiĭ VI
    Stomatologiia (Mosk); 1989; 68(5):45-9. PubMed ID: 2588280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.